This drug wholesaler's transformation is paying off. Here's why the stock still looks attractive
The largest of America's three big drug wholesalers has outperformed the market this year, but is trading at a discount to its five-year median multiple.
This is a brief. The reporting belongs to CNBC — read the complete story, with full context and credits, at the source.
Read the full story at CNBC ↗cnbc.com
More from the Business desk
Just in
Trump Administration Delays Enforcement of Medicaid Work Requirement
Just in
Nationwide FAA ground stop: nearly 11,000 flights delayed or canceled at airports across the US
Just in
Wall Street Makes Its Pitch For Anthropic’s I.P.O.
Just in